Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Paclitaxel-Coated PTA Balloon Catheter Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Paclitaxel-Coated PTA Balloon Catheter Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-11-02
Pages: 171 Pages
Report ld: 5343373
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Paclitaxel-Coated PTA Balloon Catheter Market Size(US$)
CAGR 2025-2031
4.9%
Market Size,2031
USD 354
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 266 million
Market Forecast in 2031(Value)
US$ 354 million
CAGR
4.9%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Paclitaxel-Coated PTA Balloon Catheter market is projected to grow from US$ 255 million in 2024 to US$ 354 million by 2031, at a CAGR of 4.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
A paclitaxel-coated PTA balloon catheter is a specialized medical device used in interventional cardiology and vascular interventions. It is designed to dilate narrowed or blocked blood vessels (arteries or veins) in a procedure known as angioplasty. The catheter is coated with paclitaxel, a drug that inhibits cell proliferation and helps prevent restenosis, which is the re-narrowing of the treated blood vessel after angioplasty.
The demand for paclitaxel-coated PTA balloon catheters has grown significantly over the years due to their potential to improve long-term outcomes in patients undergoing angioplasty. These devices are used in interventional cardiology and vascular surgery settings worldwide.
The effectiveness of paclitaxel-coated PTA balloon catheters in reducing restenosis rates and improving clinical outcomes has been demonstrated in various clinical studies and trials. The ongoing research and development in the field contribute to the expansion of the market and the improvement of catheter designs.
The global paclitaxel-coated PTA balloon catheter market has shown significant potential for growth due to its clinical benefits and increasing adoption in various healthcare facilities. Key players in the medical device industry are actively involved in the development and commercialization of these devices, contributing to market competition and innovation.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Paclitaxel-Coated PTA Balloon Catheter market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Boston Scientific
- Medtronic
- Cardionovum
- QT Vascular
- Meril Life Sciences
- Aachen Resonance Entwicklungsgesellschaft
- Biotronik
- Hemoteq
- Eucatech
- B.Braun
- Biosensors International
- Eurocor
- Invamed
- IVascular
- Lutonix
- Zylox-Tonbridge
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Balloon Diameter 2-4 mm
- Balloon Diameter 4-8 mm
- Others
Segment by Application
- Hospitals
- Clinics
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Paclitaxel-Coated PTA Balloon Catheter study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Paclitaxel-Coated PTA Balloon Catheter: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Paclitaxel-Coated PTA Balloon Catheter Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Balloon Diameter 2-4 mm
1.2.3 Balloon Diameter 4-8 mm
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Paclitaxel-Coated PTA Balloon Catheter Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Paclitaxel-Coated PTA Balloon Catheter Revenue Estimates and Forecasts 2020-2031
2.2 Global Paclitaxel-Coated PTA Balloon Catheter Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Paclitaxel-Coated PTA Balloon Catheter Sales Estimates and Forecasts 2020-2031
2.4 Global Paclitaxel-Coated PTA Balloon Catheter Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Paclitaxel-Coated PTA Balloon Catheter Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Paclitaxel-Coated PTA Balloon Catheter Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Balloon Diameter 2-4 mm Market Size by Manufacturers
3.5.2 Balloon Diameter 4-8 mm Market Size by Manufacturers
3.5.3 Others Market Size by Manufacturers
3.6 Global Paclitaxel-Coated PTA Balloon Catheter Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Paclitaxel-Coated PTA Balloon Catheter Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Paclitaxel-Coated PTA Balloon Catheter Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Paclitaxel-Coated PTA Balloon Catheter Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Paclitaxel-Coated PTA Balloon Catheter Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Paclitaxel-Coated PTA Balloon Catheter Sales and Revenue by Type (2020-2031)
6.4 North America Paclitaxel-Coated PTA Balloon Catheter Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Paclitaxel-Coated PTA Balloon Catheter Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Paclitaxel-Coated PTA Balloon Catheter Sales and Revenue by Type (2020-2031)
7.4 Europe Paclitaxel-Coated PTA Balloon Catheter Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Paclitaxel-Coated PTA Balloon Catheter Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Paclitaxel-Coated PTA Balloon Catheter Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Paclitaxel-Coated PTA Balloon Catheter Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Paclitaxel-Coated PTA Balloon Catheter Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Paclitaxel-Coated PTA Balloon Catheter Sales and Revenue by Type (2020-2031)
9.4 Central and South America Paclitaxel-Coated PTA Balloon Catheter Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Paclitaxel-Coated PTA Balloon Catheter Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Paclitaxel-Coated PTA Balloon Catheter Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Paclitaxel-Coated PTA Balloon Catheter Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Paclitaxel-Coated PTA Balloon Catheter Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Boston Scientific
11.1.1 Boston Scientific Corporation Information
11.1.2 Boston Scientific Business Overview
11.1.3 Boston Scientific Paclitaxel-Coated PTA Balloon Catheter Product Models, Descriptions and Specifications
11.1.4 Boston Scientific Paclitaxel-Coated PTA Balloon Catheter Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Boston Scientific Paclitaxel-Coated PTA Balloon Catheter Sales by Product in 2024
11.1.6 Boston Scientific Paclitaxel-Coated PTA Balloon Catheter Sales by Application in 2024
11.1.7 Boston Scientific Paclitaxel-Coated PTA Balloon Catheter Sales by Geographic Area in 2024
11.1.8 Boston Scientific Paclitaxel-Coated PTA Balloon Catheter SWOT Analysis
11.1.9 Boston Scientific Recent Developments
11.2 Medtronic
11.2.1 Medtronic Corporation Information
11.2.2 Medtronic Business Overview
11.2.3 Medtronic Paclitaxel-Coated PTA Balloon Catheter Product Models, Descriptions and Specifications
11.2.4 Medtronic Paclitaxel-Coated PTA Balloon Catheter Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Medtronic Paclitaxel-Coated PTA Balloon Catheter Sales by Product in 2024
11.2.6 Medtronic Paclitaxel-Coated PTA Balloon Catheter Sales by Application in 2024
11.2.7 Medtronic Paclitaxel-Coated PTA Balloon Catheter Sales by Geographic Area in 2024
11.2.8 Medtronic Paclitaxel-Coated PTA Balloon Catheter SWOT Analysis
11.2.9 Medtronic Recent Developments
11.3 Cardionovum
11.3.1 Cardionovum Corporation Information
11.3.2 Cardionovum Business Overview
11.3.3 Cardionovum Paclitaxel-Coated PTA Balloon Catheter Product Models, Descriptions and Specifications
11.3.4 Cardionovum Paclitaxel-Coated PTA Balloon Catheter Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Cardionovum Paclitaxel-Coated PTA Balloon Catheter Sales by Product in 2024
11.3.6 Cardionovum Paclitaxel-Coated PTA Balloon Catheter Sales by Application in 2024
11.3.7 Cardionovum Paclitaxel-Coated PTA Balloon Catheter Sales by Geographic Area in 2024
11.3.8 Cardionovum Paclitaxel-Coated PTA Balloon Catheter SWOT Analysis
11.3.9 Cardionovum Recent Developments
11.4 QT Vascular
11.4.1 QT Vascular Corporation Information
11.4.2 QT Vascular Business Overview
11.4.3 QT Vascular Paclitaxel-Coated PTA Balloon Catheter Product Models, Descriptions and Specifications
11.4.4 QT Vascular Paclitaxel-Coated PTA Balloon Catheter Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 QT Vascular Paclitaxel-Coated PTA Balloon Catheter Sales by Product in 2024
11.4.6 QT Vascular Paclitaxel-Coated PTA Balloon Catheter Sales by Application in 2024
11.4.7 QT Vascular Paclitaxel-Coated PTA Balloon Catheter Sales by Geographic Area in 2024
11.4.8 QT Vascular Paclitaxel-Coated PTA Balloon Catheter SWOT Analysis
11.4.9 QT Vascular Recent Developments
11.5 Meril Life Sciences
11.5.1 Meril Life Sciences Corporation Information
11.5.2 Meril Life Sciences Business Overview
11.5.3 Meril Life Sciences Paclitaxel-Coated PTA Balloon Catheter Product Models, Descriptions and Specifications
11.5.4 Meril Life Sciences Paclitaxel-Coated PTA Balloon Catheter Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Meril Life Sciences Paclitaxel-Coated PTA Balloon Catheter Sales by Product in 2024
11.5.6 Meril Life Sciences Paclitaxel-Coated PTA Balloon Catheter Sales by Application in 2024
11.5.7 Meril Life Sciences Paclitaxel-Coated PTA Balloon Catheter Sales by Geographic Area in 2024
11.5.8 Meril Life Sciences Paclitaxel-Coated PTA Balloon Catheter SWOT Analysis
11.5.9 Meril Life Sciences Recent Developments
11.6 Aachen Resonance Entwicklungsgesellschaft
11.6.1 Aachen Resonance Entwicklungsgesellschaft Corporation Information
11.6.2 Aachen Resonance Entwicklungsgesellschaft Business Overview
11.6.3 Aachen Resonance Entwicklungsgesellschaft Paclitaxel-Coated PTA Balloon Catheter Product Models, Descriptions and Specifications
11.6.4 Aachen Resonance Entwicklungsgesellschaft Paclitaxel-Coated PTA Balloon Catheter Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Aachen Resonance Entwicklungsgesellschaft Recent Developments
11.7 Biotronik
11.7.1 Biotronik Corporation Information
11.7.2 Biotronik Business Overview
11.7.3 Biotronik Paclitaxel-Coated PTA Balloon Catheter Product Models, Descriptions and Specifications
11.7.4 Biotronik Paclitaxel-Coated PTA Balloon Catheter Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Biotronik Recent Developments
11.8 Hemoteq
11.8.1 Hemoteq Corporation Information
11.8.2 Hemoteq Business Overview
11.8.3 Hemoteq Paclitaxel-Coated PTA Balloon Catheter Product Models, Descriptions and Specifications
11.8.4 Hemoteq Paclitaxel-Coated PTA Balloon Catheter Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Hemoteq Recent Developments
11.9 Eucatech
11.9.1 Eucatech Corporation Information
11.9.2 Eucatech Business Overview
11.9.3 Eucatech Paclitaxel-Coated PTA Balloon Catheter Product Models, Descriptions and Specifications
11.9.4 Eucatech Paclitaxel-Coated PTA Balloon Catheter Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Eucatech Recent Developments
11.10 B.Braun
11.10.1 B.Braun Corporation Information
11.10.2 B.Braun Business Overview
11.10.3 B.Braun Paclitaxel-Coated PTA Balloon Catheter Product Models, Descriptions and Specifications
11.10.4 B.Braun Paclitaxel-Coated PTA Balloon Catheter Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 B.Braun Recent Developments
11.11 Biosensors International
11.11.1 Biosensors International Corporation Information
11.11.2 Biosensors International Business Overview
11.11.3 Biosensors International Paclitaxel-Coated PTA Balloon Catheter Product Models, Descriptions and Specifications
11.11.4 Biosensors International Paclitaxel-Coated PTA Balloon Catheter Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Biosensors International Recent Developments
11.12 Eurocor
11.12.1 Eurocor Corporation Information
11.12.2 Eurocor Business Overview
11.12.3 Eurocor Paclitaxel-Coated PTA Balloon Catheter Product Models, Descriptions and Specifications
11.12.4 Eurocor Paclitaxel-Coated PTA Balloon Catheter Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Eurocor Recent Developments
11.13 Invamed
11.13.1 Invamed Corporation Information
11.13.2 Invamed Business Overview
11.13.3 Invamed Paclitaxel-Coated PTA Balloon Catheter Product Models, Descriptions and Specifications
11.13.4 Invamed Paclitaxel-Coated PTA Balloon Catheter Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Invamed Recent Developments
11.14 IVascular
11.14.1 IVascular Corporation Information
11.14.2 IVascular Business Overview
11.14.3 IVascular Paclitaxel-Coated PTA Balloon Catheter Product Models, Descriptions and Specifications
11.14.4 IVascular Paclitaxel-Coated PTA Balloon Catheter Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 IVascular Recent Developments
11.15 Lutonix
11.15.1 Lutonix Corporation Information
11.15.2 Lutonix Business Overview
11.15.3 Lutonix Paclitaxel-Coated PTA Balloon Catheter Product Models, Descriptions and Specifications
11.15.4 Lutonix Paclitaxel-Coated PTA Balloon Catheter Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Lutonix Recent Developments
11.16 Zylox-Tonbridge
11.16.1 Zylox-Tonbridge Corporation Information
11.16.2 Zylox-Tonbridge Business Overview
11.16.3 Zylox-Tonbridge Paclitaxel-Coated PTA Balloon Catheter Product Models, Descriptions and Specifications
11.16.4 Zylox-Tonbridge Paclitaxel-Coated PTA Balloon Catheter Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 Zylox-Tonbridge Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Paclitaxel-Coated PTA Balloon Catheter Industry Chain
12.2 Paclitaxel-Coated PTA Balloon Catheter Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Paclitaxel-Coated PTA Balloon Catheter Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Paclitaxel-Coated PTA Balloon Catheter Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Paclitaxel-Coated PTA Balloon Catheter Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Paclitaxel-Coated PTA Balloon Catheter Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Paclitaxel-Coated PTA Balloon Catheter Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Paclitaxel-Coated PTA Balloon Catheter Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Paclitaxel-Coated PTA Balloon Catheter Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Paclitaxel-Coated PTA Balloon Catheter Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Paclitaxel-Coated PTA Balloon Catheter Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Paclitaxel-Coated PTA Balloon Catheter Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Paclitaxel-Coated PTA Balloon Catheter Sales by Region (2020-2025) & (K Units)
Table 8. Global Paclitaxel-Coated PTA Balloon Catheter Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Paclitaxel-Coated PTA Balloon Catheter Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Paclitaxel-Coated PTA Balloon Catheter Sales Share by Manufacturers (2020-2025)
Table 12. Global Paclitaxel-Coated PTA Balloon Catheter Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Paclitaxel-Coated PTA Balloon Catheter Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Paclitaxel-Coated PTA Balloon Catheter by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paclitaxel-Coated PTA Balloon Catheter as of 2024)
Table 16. Global Paclitaxel-Coated PTA Balloon Catheter Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Paclitaxel-Coated PTA Balloon Catheter Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Paclitaxel-Coated PTA Balloon Catheter Manufacturing Base and Headquarters
Table 19. Global Paclitaxel-Coated PTA Balloon Catheter Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Paclitaxel-Coated PTA Balloon Catheter Sales by Type (2020-2025) & (K Units)
Table 23. Global Paclitaxel-Coated PTA Balloon Catheter Sales by Type (2026-2031) & (K Units)
Table 24. Global Paclitaxel-Coated PTA Balloon Catheter Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Paclitaxel-Coated PTA Balloon Catheter Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Paclitaxel-Coated PTA Balloon Catheter ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Paclitaxel-Coated PTA Balloon Catheter Sales by Application (2020-2025) & (K Units)
Table 29. Global Paclitaxel-Coated PTA Balloon Catheter Sales by Application (2026-2031) & (K Units)
Table 30. Paclitaxel-Coated PTA Balloon Catheter High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Paclitaxel-Coated PTA Balloon Catheter Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Paclitaxel-Coated PTA Balloon Catheter Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Paclitaxel-Coated PTA Balloon Catheter ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Paclitaxel-Coated PTA Balloon Catheter Growth Accelerators and Market Barriers
Table 37. North America Paclitaxel-Coated PTA Balloon Catheter Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Paclitaxel-Coated PTA Balloon Catheter Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Paclitaxel-Coated PTA Balloon Catheter Growth Accelerators and Market Barriers
Table 40. Europe Paclitaxel-Coated PTA Balloon Catheter Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Paclitaxel-Coated PTA Balloon Catheter Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Paclitaxel-Coated PTA Balloon Catheter Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Paclitaxel-Coated PTA Balloon Catheter Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Paclitaxel-Coated PTA Balloon Catheter Growth Accelerators and Market Barriers
Table 45. Southeast Asia Paclitaxel-Coated PTA Balloon Catheter Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Paclitaxel-Coated PTA Balloon Catheter Investment Opportunities and Key Challenges
Table 47. Central and South America Paclitaxel-Coated PTA Balloon Catheter Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Paclitaxel-Coated PTA Balloon Catheter Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Paclitaxel-Coated PTA Balloon Catheter Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Boston Scientific Corporation Information
Table 51. Boston Scientific Description and Major Businesses
Table 52. Boston Scientific Product Models, Descriptions and Specifications
Table 53. Boston Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Boston Scientific Sales Value Proportion by Product in 2024
Table 55. Boston Scientific Sales Value Proportion by Application in 2024
Table 56. Boston Scientific Sales Value Proportion by Geographic Area in 2024
Table 57. Boston Scientific Paclitaxel-Coated PTA Balloon Catheter SWOT Analysis
Table 58. Boston Scientific Recent Developments
Table 59. Medtronic Corporation Information
Table 60. Medtronic Description and Major Businesses
Table 61. Medtronic Product Models, Descriptions and Specifications
Table 62. Medtronic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Medtronic Sales Value Proportion by Product in 2024
Table 64. Medtronic Sales Value Proportion by Application in 2024
Table 65. Medtronic Sales Value Proportion by Geographic Area in 2024
Table 66. Medtronic Paclitaxel-Coated PTA Balloon Catheter SWOT Analysis
Table 67. Medtronic Recent Developments
Table 68. Cardionovum Corporation Information
Table 69. Cardionovum Description and Major Businesses
Table 70. Cardionovum Product Models, Descriptions and Specifications
Table 71. Cardionovum Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Cardionovum Sales Value Proportion by Product in 2024
Table 73. Cardionovum Sales Value Proportion by Application in 2024
Table 74. Cardionovum Sales Value Proportion by Geographic Area in 2024
Table 75. Cardionovum Paclitaxel-Coated PTA Balloon Catheter SWOT Analysis
Table 76. Cardionovum Recent Developments
Table 77. QT Vascular Corporation Information
Table 78. QT Vascular Description and Major Businesses
Table 79. QT Vascular Product Models, Descriptions and Specifications
Table 80. QT Vascular Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. QT Vascular Sales Value Proportion by Product in 2024
Table 82. QT Vascular Sales Value Proportion by Application in 2024
Table 83. QT Vascular Sales Value Proportion by Geographic Area in 2024
Table 84. QT Vascular Paclitaxel-Coated PTA Balloon Catheter SWOT Analysis
Table 85. QT Vascular Recent Developments
Table 86. Meril Life Sciences Corporation Information
Table 87. Meril Life Sciences Description and Major Businesses
Table 88. Meril Life Sciences Product Models, Descriptions and Specifications
Table 89. Meril Life Sciences Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Meril Life Sciences Sales Value Proportion by Product in 2024
Table 91. Meril Life Sciences Sales Value Proportion by Application in 2024
Table 92. Meril Life Sciences Sales Value Proportion by Geographic Area in 2024
Table 93. Meril Life Sciences Paclitaxel-Coated PTA Balloon Catheter SWOT Analysis
Table 94. Meril Life Sciences Recent Developments
Table 95. Aachen Resonance Entwicklungsgesellschaft Corporation Information
Table 96. Aachen Resonance Entwicklungsgesellschaft Description and Major Businesses
Table 97. Aachen Resonance Entwicklungsgesellschaft Product Models, Descriptions and Specifications
Table 98. Aachen Resonance Entwicklungsgesellschaft Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Aachen Resonance Entwicklungsgesellschaft Recent Developments
Table 100. Biotronik Corporation Information
Table 101. Biotronik Description and Major Businesses
Table 102. Biotronik Product Models, Descriptions and Specifications
Table 103. Biotronik Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Biotronik Recent Developments
Table 105. Hemoteq Corporation Information
Table 106. Hemoteq Description and Major Businesses
Table 107. Hemoteq Product Models, Descriptions and Specifications
Table 108. Hemoteq Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Hemoteq Recent Developments
Table 110. Eucatech Corporation Information
Table 111. Eucatech Description and Major Businesses
Table 112. Eucatech Product Models, Descriptions and Specifications
Table 113. Eucatech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Eucatech Recent Developments
Table 115. B.Braun Corporation Information
Table 116. B.Braun Description and Major Businesses
Table 117. B.Braun Product Models, Descriptions and Specifications
Table 118. B.Braun Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. B.Braun Recent Developments
Table 120. Biosensors International Corporation Information
Table 121. Biosensors International Description and Major Businesses
Table 122. Biosensors International Product Models, Descriptions and Specifications
Table 123. Biosensors International Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Biosensors International Recent Developments
Table 125. Eurocor Corporation Information
Table 126. Eurocor Description and Major Businesses
Table 127. Eurocor Product Models, Descriptions and Specifications
Table 128. Eurocor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Eurocor Recent Developments
Table 130. Invamed Corporation Information
Table 131. Invamed Description and Major Businesses
Table 132. Invamed Product Models, Descriptions and Specifications
Table 133. Invamed Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Invamed Recent Developments
Table 135. IVascular Corporation Information
Table 136. IVascular Description and Major Businesses
Table 137. IVascular Product Models, Descriptions and Specifications
Table 138. IVascular Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. IVascular Recent Developments
Table 140. Lutonix Corporation Information
Table 141. Lutonix Description and Major Businesses
Table 142. Lutonix Product Models, Descriptions and Specifications
Table 143. Lutonix Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. Lutonix Recent Developments
Table 145. Zylox-Tonbridge Corporation Information
Table 146. Zylox-Tonbridge Description and Major Businesses
Table 147. Zylox-Tonbridge Product Models, Descriptions and Specifications
Table 148. Zylox-Tonbridge Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 149. Zylox-Tonbridge Recent Developments
Table 150. Key Raw Materials Distribution
Table 151. Raw Materials Key Suppliers
Table 152. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 153. Milestones in Production Technology Evolution
Table 154. Distributors List
Table 155. Market Trends and Market Evolution
Table 156. Market Drivers and Opportunities
Table 157. Market Challenges, Risks, and Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Paclitaxel-Coated PTA Balloon Catheter Product Picture
Figure 2. Global Paclitaxel-Coated PTA Balloon Catheter Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Balloon Diameter 2-4 mm Product Picture
Figure 4. Balloon Diameter 4-8 mm Product Picture
Figure 5. Others Product Picture
Figure 6. Global Paclitaxel-Coated PTA Balloon Catheter Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Hospitals
Figure 8. Clinics
Figure 9. Others
Figure 10. Paclitaxel-Coated PTA Balloon Catheter Report Years Considered
Figure 11. Global Paclitaxel-Coated PTA Balloon Catheter Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Paclitaxel-Coated PTA Balloon Catheter Revenue (2020-2031) & (US$ Million)
Figure 13. Global Paclitaxel-Coated PTA Balloon Catheter Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Paclitaxel-Coated PTA Balloon Catheter Revenue Market Share by Region (2020-2031)
Figure 15. Global Paclitaxel-Coated PTA Balloon Catheter Sales (2020-2031) & (K Units)
Figure 16. Global Paclitaxel-Coated PTA Balloon Catheter Sales (CAGR) by Region (2020-2031) (K Units)
Figure 17. Global Paclitaxel-Coated PTA Balloon Catheter Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Paclitaxel-Coated PTA Balloon Catheter Sales Volume Market Share in 2024
Figure 19. Global Paclitaxel-Coated PTA Balloon Catheter Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Balloon Diameter 2-4 mm Revenue Market Share by Manufacturer in 2024
Figure 22. Balloon Diameter 4-8 mm Revenue Market Share by Manufacturer in 2024
Figure 23. Others Revenue Market Share by Manufacturer in 2024
Figure 24. Global Paclitaxel-Coated PTA Balloon Catheter Sales Market Share by Type (2020-2031)
Figure 25. Global Paclitaxel-Coated PTA Balloon Catheter Revenue Market Share by Type (2020-2031)
Figure 26. Global Paclitaxel-Coated PTA Balloon Catheter Sales Market Share by Application (2020-2031)
Figure 27. Global Paclitaxel-Coated PTA Balloon Catheter Revenue Market Share by Application (2020-2031)
Figure 28. North America Paclitaxel-Coated PTA Balloon Catheter Sales YoY (2020-2031) & (K Units)
Figure 29. North America Paclitaxel-Coated PTA Balloon Catheter Revenue YoY (2020-2031) & (US$ Million)
Figure 30. North America Top 5 Manufacturers Paclitaxel-Coated PTA Balloon Catheter Sales Revenue (US$ Million) in 2024
Figure 31. North America Paclitaxel-Coated PTA Balloon Catheter Sales Volume (K Units) by Type (2020- 2031)
Figure 32. North America Paclitaxel-Coated PTA Balloon Catheter Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 33. North America Paclitaxel-Coated PTA Balloon Catheter Sales Volume (K Units) by Application (2020-2031)
Figure 34. North America Paclitaxel-Coated PTA Balloon Catheter Sales Revenue (US$ Million) by Application (2020-2031)
Figure 35. US Paclitaxel-Coated PTA Balloon Catheter Revenue (2020-2031) & (US$ Million)
Figure 36. Canada Paclitaxel-Coated PTA Balloon Catheter Revenue (2020-2031) & (US$ Million)
Figure 37. Mexico Paclitaxel-Coated PTA Balloon Catheter Revenue (2020-2031) & (US$ Million)
Figure 38. Europe Paclitaxel-Coated PTA Balloon Catheter Sales YoY (2020-2031) & (K Units)
Figure 39. Europe Paclitaxel-Coated PTA Balloon Catheter Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Europe Top 5 Manufacturers Paclitaxel-Coated PTA Balloon Catheter Sales Revenue (US$ Million) in 2024
Figure 41. Europe Paclitaxel-Coated PTA Balloon Catheter Sales Volume (K Units) by Type (2020-2031)
Figure 42. Europe Paclitaxel-Coated PTA Balloon Catheter Sales Revenue (US$ Million) by Type (2020-2031)
Figure 43. Europe Paclitaxel-Coated PTA Balloon Catheter Sales Volume (K Units) by Application (2020-2031)
Figure 44. Europe Paclitaxel-Coated PTA Balloon Catheter Sales Revenue (US$ Million) by Application (2020-2031)
Figure 45. Germany Paclitaxel-Coated PTA Balloon Catheter Revenue (2020-2031) & (US$ Million)
Figure 46. France Paclitaxel-Coated PTA Balloon Catheter Revenue (2020-2031) & (US$ Million)
Figure 47. U.K. Paclitaxel-Coated PTA Balloon Catheter Revenue (2020-2031) & (US$ Million)
Figure 48. Italy Paclitaxel-Coated PTA Balloon Catheter Revenue (2020-2031) & (US$ Million)
Figure 49. Russia Paclitaxel-Coated PTA Balloon Catheter Revenue (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Paclitaxel-Coated PTA Balloon Catheter Sales YoY (2020-2031) & (K Units)
Figure 51. Asia-Pacific Paclitaxel-Coated PTA Balloon Catheter Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Top 8 Manufacturers Paclitaxel-Coated PTA Balloon Catheter Sales Revenue (US$ Million) in 2024
Figure 53. Asia-Pacific Paclitaxel-Coated PTA Balloon Catheter Sales Volume (K Units) by Type (2020- 2031)
Figure 54. Asia-Pacific Paclitaxel-Coated PTA Balloon Catheter Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 55. Asia-Pacific Paclitaxel-Coated PTA Balloon Catheter Sales Volume (K Units) by Application (2020-2031)
Figure 56. Asia-Pacific Paclitaxel-Coated PTA Balloon Catheter Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Indonesia Paclitaxel-Coated PTA Balloon Catheter Revenue (2020-2031) & (US$ Million)
Figure 58. Japan Paclitaxel-Coated PTA Balloon Catheter Revenue (2020-2031) & (US$ Million)
Figure 59. South Korea Paclitaxel-Coated PTA Balloon Catheter Revenue (2020-2031) & (US$ Million)
Figure 60. China Taiwan Paclitaxel-Coated PTA Balloon Catheter Revenue (2020-2031) & (US$ Million)
Figure 61. India Paclitaxel-Coated PTA Balloon Catheter Revenue (2020-2031) & (US$ Million)
Figure 62. Central and South America Paclitaxel-Coated PTA Balloon Catheter Sales YoY (2020-2031) & (K Units)
Figure 63. Central and South America Paclitaxel-Coated PTA Balloon Catheter Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Central and South America Top 5 Manufacturers Paclitaxel-Coated PTA Balloon Catheter Sales Revenue (US$ Million) in 2024
Figure 65. Central and South America Paclitaxel-Coated PTA Balloon Catheter Sales Volume (K Units) by Type (2021-2031)
Figure 66. Central and South America Paclitaxel-Coated PTA Balloon Catheter Sales Revenue (US$ Million) by Type (2020-2031)
Figure 67. Central and South America Paclitaxel-Coated PTA Balloon Catheter Sales Volume (K Units) by Application (2020-2031)
Figure 68. Central and South America Paclitaxel-Coated PTA Balloon Catheter Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Brazil Paclitaxel-Coated PTA Balloon Catheter Revenue (2020-2025) & (US$ Million)
Figure 70. Argentina Paclitaxel-Coated PTA Balloon Catheter Revenue (2020-2025) & (US$ Million)
Figure 71. Middle East, and Africa Paclitaxel-Coated PTA Balloon Catheter Sales YoY (2020-2031) & (K Units)
Figure 72. Middle East and Africa Paclitaxel-Coated PTA Balloon Catheter Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Middle East and Africa Top 5 Manufacturers Paclitaxel-Coated PTA Balloon Catheter Sales Revenue (US$ Million) in 2024
Figure 74. Middle East and Africa Paclitaxel-Coated PTA Balloon Catheter Sales Volume (K Units) by Type (2021-2031)
Figure 75. South America Paclitaxel-Coated PTA Balloon Catheter Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Middle East and Africa Paclitaxel-Coated PTA Balloon Catheter Sales Volume (K Units) by Application (2020-2031)
Figure 77. Middle East and Africa Paclitaxel-Coated PTA Balloon Catheter Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. GCC Countries Paclitaxel-Coated PTA Balloon Catheter Revenue (2020-2025) & (US$ Million)
Figure 79. Turkey Paclitaxel-Coated PTA Balloon Catheter Revenue (2020-2025) & (US$ Million)
Figure 80. Egypt Paclitaxel-Coated PTA Balloon Catheter Revenue (2020-2025) & (US$ Million)
Figure 81. South Africa Paclitaxel-Coated PTA Balloon Catheter Revenue (2020-2025) & (US$ Million)
Figure 82. Paclitaxel-Coated PTA Balloon Catheter Industry Chain Mapping
Figure 83. Regional Paclitaxel-Coated PTA Balloon Catheter Manufacturing Base Distribution (%)
Figure 84. Global Paclitaxel-Coated PTA Balloon Catheter Production Market Share by Region (2020-2031)
Figure 85. Paclitaxel-Coated PTA Balloon Catheter Production Process
Figure 86. Regional Paclitaxel-Coated PTA Balloon Catheter Production Cost Structure
Figure 87. Channels of Distribution (Direct Vs Distribution)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Paclitaxel-Coated PTA Balloon Catheter market?
The top companies in the global Paclitaxel-Coated PTA Balloon Catheter market are Boston Scientific、Medtronic、Cardionovum.
What was the global market size of Paclitaxel-Coated PTA Balloon Catheter in 2031?
What was the global market size of Paclitaxel-Coated PTA Balloon Catheter in 2025?
Which region is expected to have the highest market share?
What is the annual compound growth rate of the global Paclitaxel-Coated PTA Balloon Catheter market size from 2025 to 2031?
Related Reports
Paclitaxel-Coated PTA Balloon Catheter- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Paclitaxel-Coated PTA Balloon Catheter was estimated to be worth US$ 266 million in 2025 and is projected to reach US$ 370 million, growing at a CAGR of 4.9% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 150
USD 3950.00
(Single User License)
Global Paclitaxel-Coated PTA Balloon Catheter Market Research Report 2026
The global Paclitaxel-Coated PTA Balloon Catheter market was valued at US$ 266 million in 2025 and is anticipated to reach US$ 370 million by 2032, at a CAGR of 4.9% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 131
USD 2900.00
(Single User License)
Global Paclitaxel-Coated PTA Balloon Catheter Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Paclitaxel-Coated PTA Balloon Catheter market size was US$ 255 million in 2024 and is forecast to a readjusted size of US$ 354 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 108
USD 4250.00
(Single User License)
Paclitaxel-Coated PTA Balloon Catheter- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Paclitaxel-Coated PTA Balloon Catheter was estimated to be worth US$ 255 million in 2024 and is forecast to a readjusted size of US$ 354 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 135
USD 3950.00
(Single User License)
Global Paclitaxel-Coated PTA Balloon Catheter Market Research Report 2025
The global market for Paclitaxel-Coated PTA Balloon Catheter was valued at US$ 255 million in the year 2024 and is projected to reach a revised size of US$ 354 million by 2031, growing at a CAGR of 4.9% during the forecast period.
Published Date: 2025-01-13
Pages: 98
USD 2900.00
(Single User License)
Global Paclitaxel-Coated PTA Balloon Catheter Market Research Report 2024
Published Date: 2024-02-05
Pages: 98
USD 2900.00
(Single User License)
Paclitaxel-Coated PTA Balloon Catheter- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Paclitaxel-Coated PTA Balloon Catheter was estimated to be worth US$ 266 million in 2025 and is projected to reach US$ 370 million, growing at a CAGR of 4.9% from 2026 to 2032.
Published: 2026-06-16
Pages: 150
USD 3950.00 (Single User License)Global Paclitaxel-Coated PTA Balloon Catheter Market Research Report 2026
The global Paclitaxel-Coated PTA Balloon Catheter market was valued at US$ 266 million in 2025 and is anticipated to reach US$ 370 million by 2032, at a CAGR of 4.9% from 2026 to 2032.
Published: 2026-04-17
Pages: 131
USD 2900.00 (Single User License)Global Paclitaxel-Coated PTA Balloon Catheter Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Paclitaxel-Coated PTA Balloon Catheter market size was US$ 255 million in 2024 and is forecast to a readjusted size of US$ 354 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 108
USD 4250.00 (Single User License)Paclitaxel-Coated PTA Balloon Catheter- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Paclitaxel-Coated PTA Balloon Catheter was estimated to be worth US$ 255 million in 2024 and is forecast to a readjusted size of US$ 354 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 135
USD 3950.00 (Single User License)Global Paclitaxel-Coated PTA Balloon Catheter Market Research Report 2025
The global market for Paclitaxel-Coated PTA Balloon Catheter was valued at US$ 255 million in the year 2024 and is projected to reach a revised size of US$ 354 million by 2031, growing at a CAGR of 4.9% during the forecast period.
Published: 2025-01-13
Pages: 98
USD 2900.00 (Single User License)Global Paclitaxel-Coated PTA Balloon Catheter Market Research Report 2024
Published: 2024-02-05
Pages: 98
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now